Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOMP-AID
NCT03438526Phase 4Recruiting
- Sponsor
- University Hospital Basel
- Start
- Jan 2022
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of melatonin in delirium, sponsored by University Hospital Basel. Started Jan 2022; status: recruiting.
02
Drugs
melatonin
03
Conditions
delirium
Beyond the preview
Go deeper on NCT03438526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03438526.